Advertisement

Topics

Immuno-Cell Company Profile

18:05 EDT 20th September 2017 | BioPortfolio

Manufacture of slides and cards for use in test kits.

Location

Motstraat 72/8
Mechelen
B-2800
Belgium

Contact

Phone: 32 15 43 31 88
Fax: 32 15 43 11 21


News Articles [2531 Associated News Articles listed on BioPortfolio]

Integral Molecular begins immuno-oncology therapeutic targets discovery

US-based research-driven biotechnology company Integral Molecular has begun a therapeutic target discovery programme in immuno-oncology by utilising its membrane proteome array technology to identify ...

Tessa, Parker Institute sign deal on cell therapies, immuno-oncology studies

Tessa Therapeutics has signed a multiyear agreement with the Parker Institute for Cancer Immunotherapy to develop cell therap -More- 

Immunology: Mind the immuno-connection gap

Biologic drugs that modulate the immune system have revolutionized the therapeutic landscape for several selected cancer types. A new study reports an image-based assay system to monitor cell–cell i...

CRISPR Therapeutics, MGH Partner to Develop T-Cell Cancer Therapies

CRISPR Therapeutics and Massachusetts General Hospital Cancer Center (MGHCC) said today they will develop novel T cell therapies for blood and solid tumors by using CRISPR/Cas9 gene editing to improve...

Merck KGaA taps Selexis cell line tech for immuno-oncology antibodies

A Merck KGaA has signed a licensing agreement for Selexis’ SUREtechnology platform and its suspension-adapted CHO-K1 cell line.

Horizon Discovery hails the impact of immuno-oncology as it restates its growth target

Gene editing specialist Horizon Discovery Group PLC (LON:HZD) said its work in immuno-oncology has become a major growth driver as it restated its bullish sales target. It has built what it describe...

Research quantifies growth in immuno-oncology combination trials

A new report looking at the booming market for immuno-oncology treatments has quantified the rise in…

TCR2 Therapeutics Named One of the 15 Innovative Immuno-Oncology Biotechs to Watch in 2018 by Immuno-Oncology Frontiers

CAMBRIDGE, Mass., Sept. 15, 2017 /PRNewswire/ -- TCR2 Therapeutics Inc. today announced that it has been named one of the "Top 15 Innovative Immuno-Oncology Biotechs to Watch in 2018" by Immuno-O...

Drugs and Medications [19 Associated Drugs and Medications listed on BioPortfolio]

Sun care [Zenith Medicosm SL]

Drug Facts

Sun care [Zenith Medicosm SL]

Drug Facts

Alimta [Eli Lilly and Company]

These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA. ALIMTA (pemetrexed for injection) Lyophilized Powder, for ...

Hycamtin [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use HYCAMTIN safely and effectively. See full prescribing information for HYCAMTIN. HYCAMTIN (topotecan) CapsulesInitial U.S. Approval: 19...

Patanol [Physicians Total Care, Inc.]

PubMed Articles [5768 Associated PubMed Articles listed on BioPortfolio]

Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells.

Chronic lymphocytic leukemia (CLL) is associated with T cell dysfunction. Activated CLL cells are found within the lymphoid tumor micro-environment and overcoming immuno-suppression induced by these c...

Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential.

Stem cell-based therapy is considered to be a new hope in transplantation medicine. Among stem cells, mesenchymal stem cells (MSCs) are, due to their differentiation and immuno-modulatory characterist...

Immuno-PCR technology for detection of natural human antibodies against Le(c) disaccharide.

The development of an immuno-PCR assay for quantitation of low amounts of anti-glycan human antibodies is described. The sensitivity of the assay for determination of low-affinity anti-Le(C) IgM has b...

Immuno-MALDI (iMALDI) for quantifying AKT1 and AKT2 in breast and colorectal cancer cell lines and tumors.

The PI3K/AKT/mTOR pathway is one of the most commonly dysregulated signaling pathways that is linked to cancer development and progression, and its quantitative protein analysis holds the promise to f...

A Case for a Human Immuno-Peptidome Project Consortium.

A multidisciplinary group of researchers gathered at the Hönggerberg Campus at ETH Zurich, Switzerland, for the first meeting on the Human Immuno-Peptidome Project (https://hupo.org/human-immuno-pept...

Clinical Trials [5786 Associated Clinical Trials listed on BioPortfolio]

Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma

Multi-center, prospective randomised phase III study evaluating capecitabine in combination with standard-immunotherapy versus standard-immunotherapy alone as first-line therapy in patient...

Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer

This study includes the additional use of radiation therapy in combination immunotherapy in order to determine whether the radiation may improve the response of non-small cell lung cancer ...

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

The purpose of this study is to evaluate the safety and effectiveness of CAR-T cell immunotherapy in treating with GD2 positive glioma patients.

Exposure Chamber Trial With Cat Immunotherapy

The main purpose of this trial is to investigate if any of three different doses of cat hair immunotherapy is safe for treatment of cat allergic patients.

Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

The purpose of this research study is to test the effectiveness of three treatment arms that are designed to improve survival in patients with non-small cell lung cancer. Eligible subjects...

Companies [973 Associated Companies listed on BioPortfolio]

Immuno-Cell Int.

Immuno-Cell International © is specialized in the production of printed diagnostic slides and plates, for use in various types of diagnostic test kits. For the Diagnostic Industry (the manufactures o...

Immuno-Cell

Manufacture of slides and cards for use in test kits.

NantCell, Inc.

NantCell, an entity controlled by Dr. Patrick Soon-Shiong, is an immuno-oncology company focused on the discovery of innovative antibody, T cell and NK cell based treatments by de...

Immuno Diagnostic Oy

Immuno Diagnostic Oy was established in 1983. Thus, we have a long experience in importing and marketing high quality reagents for diagnostics and research. We provide our customers with a wide range ...

MEDINET Co., Ltd. and MaxCyte, Inc.

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technol...

More Information about "Immuno-Cell" on BioPortfolio

We have published hundreds of Immuno-Cell news stories on BioPortfolio along with dozens of Immuno-Cell Clinical Trials and PubMed Articles about Immuno-Cell for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immuno-Cell Companies in our database. You can also find out about relevant Immuno-Cell Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record